These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34513348)

  • 1. A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder.
    Sinha S; Chary S; Thakur P; Talluri L; Reddy M; Verma KK; Saha P; Gupta VB; Ramaiah KA; Khanum SZ
    Cureus; 2021 Jul; 13(7):e16689. PubMed ID: 34513348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Rickels K; Athanasiou M; Robinson DS; Gibertini M; Whalen H; Reed CR
    J Clin Psychiatry; 2009 Mar; 70(3):326-33. PubMed ID: 19284933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study.
    Kadam RL; Sontakke SD; Tiple P; Motghare VM; Bajait CS; Kalikar MV
    Indian J Pharmacol; 2020; 52(2):79-85. PubMed ID: 32565594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder.
    Rele S; Millet R; Kim S; Paik JW; Kim S; Masand PS; Patkar AA
    Prim Care Companion CNS Disord; 2015; 17(4):. PubMed ID: 26693034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Controlled Trial Comparing Efficacy and Safety of Antidepressant Monotherapy.
    Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
    Cureus; 2024 Apr; 16(4):e59074. PubMed ID: 38800340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.
    Stein DJ; Lopez AG
    Adv Ther; 2011 Nov; 28(11):1021-37. PubMed ID: 22057726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.
    Durgam S; Chen C; Migliore R; Prakash C; Edwards J; Findling RL
    Paediatr Drugs; 2018 Aug; 20(4):353-363. PubMed ID: 29633166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of vilazodone in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Croft HA; Pomara N; Gommoll C; Chen D; Nunez R; Mathews M
    J Clin Psychiatry; 2014 Nov; 75(11):e1291-8. PubMed ID: 25470094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.
    Reed CR; Kajdasz DK; Whalen H; Athanasiou MC; Gallipoli S; Thase ME
    Curr Med Res Opin; 2012 Jan; 28(1):27-39. PubMed ID: 22106941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Mathews M; Gommoll C; Chen D; Nunez R; Khan A
    Int Clin Psychopharmacol; 2015 Mar; 30(2):67-74. PubMed ID: 25500685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trials.
    Jain R; Chen D; Edwards J; Mathews M
    Curr Med Res Opin; 2014 Feb; 30(2):263-70. PubMed ID: 24127687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2012 Apr; 66(4):356-68. PubMed ID: 22284853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vilazodone: in major depressive disorder.
    Frampton JE
    CNS Drugs; 2011 Jul; 25(7):615-27. PubMed ID: 21699273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.
    Durgam S; Gommoll C; Forero G; Nunez R; Tang X; Mathews M; Sheehan DV
    J Clin Psychiatry; 2016 Dec; 77(12):1687-1694. PubMed ID: 27232052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder.
    Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
    Cureus; 2023 Apr; 15(4):e37858. PubMed ID: 37213947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.
    Gommoll C; Forero G; Mathews M; Nunez R; Tang X; Durgam S; Sambunaris A
    Int Clin Psychopharmacol; 2015 Nov; 30(6):297-306. PubMed ID: 26291335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder.
    Zhang XF; Wu L; Wan DJ; Liu RZ; Dong Z; Chen M; Yu SY
    Neuropsychiatr Dis Treat; 2015; 11():1957-65. PubMed ID: 26345981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vilazodone: a review in major depressive disorder in adults.
    McCormack PL
    Drugs; 2015 Nov; 75(16):1915-23. PubMed ID: 26496736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.